Cannella L, Breccia M, Loglisci G, Federico V, Santopietro M, Alimena G. Safety and efficacy of nilotinib in chronic phase chronic myeloid leukemia in a patient with Wolf-Parkinson-White disease and hematological resistance after suboptimal response to imatinib at six months. AO [Internet]. 2010 Jan. 1 [cited 2026 Apr. 29];49(3):399-400. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/32601